Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 73

Sort by

Sort Order Select

Journal Articles

Clinically meaningful improvement of the modified lee symptom score in patients treated with belumosudil for steroid-refractory chronic GVHD: Evidence from Canadian real-world outcomes

Sergio Rodriguez-Rodriguez, Nihar Desai, Brittany Salter, Amani Ahmed, Mohamed Elemary, Jonas Mattsson, Kylie Lepic, Jennifer White, Dennis Kim

Blood (2025) 146 (Supplement 1): 2470.

https://doi.org/10.1182/blood-2025-2470

Published: 2025

Journal Articles

Multicenter real-world experience of belumosudil treatment in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: Clinical outcomes and risk factor analysis for failure-free survival.

Sergio Rodriguez-Rodriguez, Rebeca Bailen, Keven Vachon, Brittany Salter, Christopher Lemieux, Kareem Jamani, Mohamed Elemary, Sylvie Lachance, Jonas Mattsson, Kylie Lepic, Amani Ahmed, Jennifer White, Felipe Peña-Muñoz, Juan Alberto Martín González, Jose Antonio Perez Simon, Matthias Fante, Daniel Wolff, Mi Kwon, Dennis Kim

Blood (2025) 146 (Supplement 1): 4239.

https://doi.org/10.1182/blood-2025-4239

Published: 2025

Journal Articles

Frailty assessed by HCT-FS predicts survival and non-relapse mortality across hematologic disorders undergoing allo-HCT: A multicenter Study of 992 patients

Blood (2025) 146 (Supplement 1): 2652.

https://doi.org/10.1182/blood-2025-2652

Published: 2025

Journal Articles

Relapse with post-transplant tyrosine kinase inhibitor (TKI) maintenance therapy in phliladelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) after allogeneic hematopoietic stem cell transplantation: Incidence and risk factor analysis

Eshrak Al-Shaibani, Jonas Mattsson, Yu Cai, Xianmin Song, Mohsen Al Zahrani, Mohamed Elemary, Hanan Alkhaldi, Muhned Alhumaid, Ayman Saad, Francesca Biavasco, Robert Zeiser, Dennis Kim

Blood (2025) 146 (Supplement 1): 4273.

https://doi.org/10.1182/blood-2025-4273

Published: 2025

Journal Articles

Comparison of alemtuzumab and ATG-based conditioning in adult recipients of allogeneic hematopoietic cell transplantation (HCT) for severe aplastic anemia: A retrospective study

Murad Almowarey, Nihar Desai, Mohammed Kawari, Eshrak Al-Shaibani, Tommy Alfaro Moya, Arjun Law, Igor Novitzky-Basso, Ivan Pasic, Fotios Michelis, Auro Viswabandya, Dennis Kim, Jonas Mattsson, Rajat Kumar

Blood (2025) 146 (Supplement 1): 4207.

https://doi.org/10.1182/blood-2025-4207

Published: 2025

Journal Articles

Propensity score matching analysis comparing the efficacy and treatment outcomes of belumosudil treatment with ruxolitinib therapy as second-line or beyond in chronic GVHD patients after steroid failure

Blood (2025) 146 (Supplement 1): 6031.

https://doi.org/10.1182/blood-2025-6031

Published: 2025

Journal Articles

Propensity score matching analysis comparing the efficacy and long-term outcomes of belumosudil to the best available treatment as a historical control, used as second-line therapy or beyond for chronic GVHD after steroid failure.

Blood (2025) 146 (Supplement 1): 6025.

https://doi.org/10.1182/blood-2025-6025

Published: 2025

Journal Articles

Factors influencing outcomes in therapy-related myeloid neoplasms following allogeneic hematopoietic stem cell transplantation

Noora Obaidallah, Sihath Singhabahu, Mats Remberger, Dennis Kim, Auro Viswabandya, Rajat Kumar, Fotios Michelis, Arjun Law, Igor Novitzky-Basso, Tommy Alfaro Moya, Eshrak Al-Shaibani, Jonas Mattsson, Ivan Pasic

Blood (2025) 146 (Supplement 1): 7823.

https://doi.org/10.1182/blood-2025-7823

Published: 2025

Journal Articles

Frailty as a prognostic factor in younger adult patients with Acute Myeloid Leukemia undergoing allogeneic stem cell transplantation

Sergio Rodriguez-Rodriguez, Nihar Desai, Maria Queralt Salas Gay, Eshrak Al-Shaibani, Igor Novitzky-Basso, Arjun Law, Auro Viswabandya, Fotios Michelis, Jonas Mattsson, Dennis Kim, Rajat Kumar, Tommy Alfaro Moya

Blood (2025) 146 (Supplement 1): 4430.

https://doi.org/10.1182/blood-2025-4430

Published: 2025

Journal Articles

Post-transplant monitoring of multiparameter flow-cytometry (MFC)-based measurable residual disease (MRD) assessment combined with T-cell chimerism following allogeneic stem cell transplantation (HCT) in Acute Myeloid Leukemia (AML) and myelodysplastic syndrome (MDS)

Reem Alasbali, Majed Altareb, Carol Chen, Tommy Alfaro Moya, Eshrak Al-Shaibani, Swe Linn, Ivan Pasic, Igor Novitzky-Basso, Arjun Law, Fotios Michelis, Auro Viswabandya, Rajat Kumar, Jonas Mattsson, Raja Prince-Eladnani, Anne Tierens, Dennis Kim

Blood (2025) 146 (Supplement 1): 4295.

https://doi.org/10.1182/blood-2025-4295

Published: 2025

Journal Articles

Tolerability and Efficacy of Post-Transplant Cyclophosphamide in Older Adults Undergoing Matched Sibling Donor Allogeneic Transplantation: A Retrospective Analysis

Nihar Desai, Tommy Alfaro Moya, Igor Novitzky-Basso, Ivan Pasic, Wilson Lam, Fotios Michelis, Armin Gerbitz, Auro Viswabandya, Dennis Dong Hwan Kim, Rajat Kumar, Jonas Mattsson, Arjun Law

Blood (2024) 144 (Supplement 1): 4883.

https://doi.org/10.1182/blood-2024-204052

Published: 2024

Journal Articles

Identification of High-Risk Patients and Establishment of a Clinical Prediction Model for Frontline Steroid Failure in Chronic Graft-Versus-Host-Disease

Arjun Pandey, Ivan Pasic, Igor Novitzky-Basso, Arjun Law, Wilson Lam, Fotios Michelis, Armin Gerbitz, Auro Viswabandya, Rajat Kumar, Jonas Mattsson, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 4899.

https://doi.org/10.1182/blood-2024-207936

Published: 2024

Journal Articles

Monocytes Matter: Impact of Monocyte Recovery on Allogeneic Hematopoietic Stem Cell Transplant Outcomes with Post-Transplantation Cyclophosphamide As Graft Versus Host Disease Prophylaxis

Nihar Desai, Tommy Alfaro Moya, Arjun Law, Wilson Lam, Igor Novitzky-Basso, Ivan Pasic, Fotios Michelis, Armin Gerbitz, Dennis Dong Hwan Kim, Rajat Kumar, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 4896.

https://doi.org/10.1182/blood-2024-204123

Published: 2024

Journal Articles

Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse

Eshrak Al-Shaibani, Yu Cai, Xianmin Song, Mohsen Al Zahrani, Mohamed Elemary, Muhned Alhumaid, Hanan Alkhaldi, Ayman Saad, Francesca Biavasco, Robert Zeiser, Joon Ho Moon, Sang Kyun Sohn, Jonas Mattsson, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 4930.

https://doi.org/10.1182/blood-2024-211761

Published: 2024

Journal Articles

Haploidentical and Mismatched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis: A Retrospective Cohort Study

Nihar Desai, Arjun Law, Igor Novitzky-Basso, Ivan Pasic, Wilson Lam, Fotios Michelis, Armin Gerbitz, Dennis Dong Hwan Kim, Rajat Kumar, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 4865.

https://doi.org/10.1182/blood-2024-204140

Published: 2024

Journal Articles

Strength to Endure: Superiority of MAC over RIC in Patients <65 Years Undergoing Stem Cell Transplantation Using ATG-Ptcy-CSA for Gvhd Prophylaxis

Ruah Alyamany, Ahmed Alnughmush, Mats Remberger, Fotios Michelis, Arjun D. Law, Wilson Lam, Dennis Dong Hwan Kim, Ivan Pasic, Igor Novitzky-Basso, Armin Gerbitz, Rajat Kumar, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 4863.

https://doi.org/10.1182/blood-2024-202536

Published: 2024

Journal Articles

Expanding the Donor Pool, the Number of Antigen Mismatches Has No Impact in the Outcomes of Haploidentical Stem Cell Transplantation with Peripheral Blood Stem Cells and Dual T Cell Depletion

Tommy Alfaro, Nihar Desai, Carol Chen, Maria Queralt Salas, Igor Novitzky-Basso, Wilson Lam, Ivan Pasic, Arjun Datt Law, Fotios Michelis, Jeffrey H. Lipton, Armin Gerbitz, Rajat Kumar, Dennis Dong Hwan Kim, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 2183.

https://doi.org/10.1182/blood-2024-199206

Published: 2024

Journal Articles

Don't Fly and Freeze: Impact of Ex-Vivo-Time, Cell Concentration and Cryopreservation on the Composition of Allogeneic Stem Cell Grafts

Blood (2024) 144 (Supplement 1): 7261.

https://doi.org/10.1182/blood-2024-210038

Published: 2024

Journal Articles

Superior Survival of Myeloablative over Reduced-Intensity Conditioning in MDS Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

Ahmed Alnughmush, Ruah Alyamany, Mats Remberger, Ivan Pasic, Igor Novitzky-Basso, Arjun Law, Wilson Lam, Dennis Dong Hwan Kim, Fotios Michelis, Armin Gerbitz, Rajat Kumar, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 7285.

https://doi.org/10.1182/blood-2024-202708

Published: 2024

Journal Articles

Both Pre- and Post-Allogeneic Stem Cell Transplant Ferritin Are Associated with Relapse: A Large Single Centre Retrospective Study

Caden Chiarello, Mats Remberger, Carol Chen, Armin Gerbitz, Dennis Dong Hwan Kim, Rajat Kumar, Wilson Lam, Arjun Law, Jonas Mattsson, Fotios Michelis, Ivan Pasic, Auro Viswabandya, Igor Novitzky-Basso

Blood (2024) 144 (Supplement 1): 7384.

https://doi.org/10.1182/blood-2024-203265

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Clinically meaningful improvement of the modified lee symptom score in patients treated with belumosudil for steroid-refractory chronic GVHD: Evidence from Canadian real-world outcomes

Multicenter real-world experience of belumosudil treatment in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: Clinical outcomes and risk factor analysis for failure-free survival.

Frailty assessed by HCT-FS predicts survival and non-relapse mortality across hematologic disorders undergoing allo-HCT: A multicenter Study of 992 patients

Relapse with post-transplant tyrosine kinase inhibitor (TKI) maintenance therapy in phliladelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) after allogeneic hematopoietic stem cell transplantation: Incidence and risk factor analysis

Comparison of alemtuzumab and ATG-based conditioning in adult recipients of allogeneic hematopoietic cell transplantation (HCT) for severe aplastic anemia: A retrospective study

Propensity score matching analysis comparing the efficacy and treatment outcomes of belumosudil treatment with ruxolitinib therapy as second-line or beyond in chronic GVHD patients after steroid failure

Propensity score matching analysis comparing the efficacy and long-term outcomes of belumosudil to the best available treatment as a historical control, used as second-line therapy or beyond for chronic GVHD after steroid failure.

Factors influencing outcomes in therapy-related myeloid neoplasms following allogeneic hematopoietic stem cell transplantation

Frailty as a prognostic factor in younger adult patients with Acute Myeloid Leukemia undergoing allogeneic stem cell transplantation

Post-transplant monitoring of multiparameter flow-cytometry (MFC)-based measurable residual disease (MRD) assessment combined with T-cell chimerism following allogeneic stem cell transplantation (HCT) in Acute Myeloid Leukemia (AML) and myelodysplastic syndrome (MDS)

Tolerability and Efficacy of Post-Transplant Cyclophosphamide in Older Adults Undergoing Matched Sibling Donor Allogeneic Transplantation: A Retrospective Analysis

Identification of High-Risk Patients and Establishment of a Clinical Prediction Model for Frontline Steroid Failure in Chronic Graft-Versus-Host-Disease

Monocytes Matter: Impact of Monocyte Recovery on Allogeneic Hematopoietic Stem Cell Transplant Outcomes with Post-Transplantation Cyclophosphamide As Graft Versus Host Disease Prophylaxis

Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse

Haploidentical and Mismatched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis: A Retrospective Cohort Study

Strength to Endure: Superiority of MAC over RIC in Patients <65 Years Undergoing Stem Cell Transplantation Using ATG-Ptcy-CSA for Gvhd Prophylaxis

Expanding the Donor Pool, the Number of Antigen Mismatches Has No Impact in the Outcomes of Haploidentical Stem Cell Transplantation with Peripheral Blood Stem Cells and Dual T Cell Depletion

Don't Fly and Freeze: Impact of Ex-Vivo-Time, Cell Concentration and Cryopreservation on the Composition of Allogeneic Stem Cell Grafts

Superior Survival of Myeloablative over Reduced-Intensity Conditioning in MDS Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

Both Pre- and Post-Allogeneic Stem Cell Transplant Ferritin Are Associated with Relapse: A Large Single Centre Retrospective Study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only